Clinical Trial

Selective Defunctioning Stoma in Low Anterior Resection for Rectal Cancer

Study acronym: SELSA
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational trial with a nested randomized controlled trial is to investigate a selective approach of defunctioning stoma in low anterior resection in rectal cancer patients. The primary outcome is a hybrid so-called textbook outcome; stoma-free survival at two years without major LARS, reflecting a functionally appropriate outcome after low anterior resection for rectal cancer. Secondary outcomes include anastomotic leakage, postoperative mortality, reinterventions, stoma-related complications, quality of life measures, LARS, and permanent stoma rate up to two years after index surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-01-17.
Status change: Not Yet Recruiting → Recruiting 2025-05-15
Trial Details
NCT Number NCT06214988
Lead Sponsor Skane University Hospital
Collaborators: Umeå University, Lund University, Göteborg University, Ersta Hospital, Sweden, Copenhagen University Hospital at Herlev, Linkoeping University, Oslo University Hospital, Örebro University, Sweden
Conditions Rectal Cancer
Enrollment 212 participants
Start Date 2024-09-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-21